首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Overexpression of TIMP-1 under the MMP-9 promoter interferes with wound healing in transgenic mice
Authors:Tuire?Salonurmi  Mataleena?Parikka  Sirpa?Kontusaari  Emma?Piril?  Carine?Munaut  Tuula?Salo  Email author" target="_blank">Karl?TryggvasonEmail author
Institution:(1) Biocenter Oulu, Department of Biochemistry, University of Oulu, Oulu, Finland;(2) Department of Dentistry, University of Oulu, Oulu, Finland;(3) Department of Dentistry, University of Helsinki, Helsinki, Finland;(4) Department of Biology, Laboratory of Tumor and Developmental Biology, University of Liege, Liege, Belgium;(5) Division of Matrix Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 171 77 Stockholm, Sweden
Abstract:We have generated transgenic mice harboring the murine matrix metalloproteinase 9 (MMP-9) promoter cloned in front of human TIMP-1 cDNA. The transgenic mice were viable and fertile and exhibited normal growth and general development. During wound healing the mice were shown to express human TIMP-1 in keratinocytes that normally express MMP-9. However, the healing of skin wounds was significantly retarded with slow migration of keratinocytes over the wound in transgenic mice. In situ zymography carried out on wound tissues revealed total blockage of gelatinolytic activity (i.e., MMP-9 and MMP-2). The results confirm studies with MMP-9 knockout mice showing that MMP-9 is not essential for general development, but they also demonstrate an important role of keratinocyte MMP-9, as well that of other keratinocyte MMPs that are inhibited by TIMP-1, in wound healing. The transgenic mice generated in this study provide a model for the role of MMPs in MMP-9-producing cells in other challenging situations such as bone fracture recovery and cancer invasion.The expert technical assistance of M. Jarva, L. Ollitervo, S. Kangas, and R. Jokisalo is gratefully acknowledged. This work was supported in part by grants from the Finnish Academy of Science, the Swedish Cancer Foundation, the Novo Nordisk Foundation and EC contract QLG1-CT-2000-01131 (K.T.), the Finnish Dental Society Apollonia and the Northern Finland Cancer Foundation (M.P.), as well as the K. Albin Johansson Foundation and the Einar and Karin Stroems Foundation (E.P.)
Keywords:Gene expression regulation  Keratinocytes  Matrix metalloproteinases  Tissue inhibitor of metalloproteinase-1  Transgenic mice
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号